Bio
Chief Scientific Officer and co-founder of LentiStem Biotech, a company focused on optimizing technologies to enhance the efficacy and safety of immunotherapy and CAR-T therapy. Ph.D. in Biomedicine from GENYO (Granada) under the supervision of Prof. Francisco Martín. With over 8 years of experience in immune cells and lentiviral vectors. Co-author of 16 publications and holder of 2 patents in immunology and cell-gene therapy.